AXA SA (ETR:AXA)
Germany · Delayed Price · Currency is EUR | Market Cap | 84.92B +2.9% |
| Revenue (ttm) | 96.79B +3.8% |
| Net Income | 9.88B +29.0% |
| EPS | 4.79 +36.5% |
| Shares Out | n/a |
| PE Ratio | 8.56 |
| Forward PE | 9.57 |
| Dividend | 2.32 (5.53%) |
| Ex-Dividend Date | May 11, 2026 |
| Volume | 11,978 |
| Open | 42.11 |
| Previous Close | 41.77 |
| Day's Range | 41.93 - 42.19 |
| 52-Week Range | 36.56 - 45.63 |
| Beta | 0.59 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Oct 29, 2026 |
About AXA SA
AXA SA, through its subsidiaries, provides insurance, asset management, and banking services worldwide. The company operates through France, Europe, AXA XL, Asia, Africa & EME-LATAM, and Transversal & Other segments. It offers life and savings insurance and property and casualty insurance products. The company also provides protection and retirement products for individual and professional customers; reinsurance coverages; property, primary and excess casualty, excess and surplus lines, environmental liability, professional liability, construct... [Read more]
Financial Performance
In 2025, AXA SA's revenue was 94.69 billion, an increase of 3.77% compared to the previous year's 91.26 billion. Earnings were 9.62 billion, an increase of 25.22%.
Financial StatementsNews
ICC ends contract with French insurer amid US sanctions threat
ICC and Axa terminate agreement amid mounting US criticism and looming financial restrictions on the court, FT reports.
ICC Faces Operational Challenges as AXA Exits Amid US Sanctions
ICC Faces Operational Challenges as AXA Exits Amid US Sanctions
ICC cuts ties with AXA over US sanctions, FT reports
The International Criminal Court has cut ties with its health insurance provider Axa in a bid to shield itself from US sanctions, the Financial Times reported on Thursday.
AXA price target lowered to EUR 52 from EUR 54 at RBC Capital
RBC Capital analyst Ben Cohen lowered the firm’s price target on AXA (AXAHY) to EUR 52 from EUR 54 and keeps an Outperform rating on the shares. Published first on…
Global insurer Axa is going cheap – should you buy?
After ten years of restructuring, global insurer Axa is now primed for growth, and the shares look like a bargain
AXA SA at Bank of America Global Research Financials CEO Conference Transcript
AXA SA at Bank of America Global Research Financials CEO Conference Transcript
AXA SA Transcript: Bank of America 31th Annual Financials CEO Conference
A new strategic plan for 2027-2029 targets organic growth, market share gains, and AI-driven productivity, with a focus on customer retention and expansion in direct and social inclusion insurance. Capital allocation remains disciplined, and the business mix shift is now delivering stable, competitive performance.
Santander wins UK appeal over $912 million AXA US PPI ruling
Santander won its appeal on Tuesday against a London court ruling that had ordered it to pay about £677 million ($912 million) to French insurer AXA for costs arising from the mis-selling of payment p...
AXA Unveils Growth Strategy Aiming for 7%-9% EPS CAGR
AXA Unveils Growth Strategy Aiming for 7%-9% EPS CAGR
Genworth responds to UK Court of Appeal ruling against AXA
Genworth Financial (GNW) issued a statement in response to a UK Court of Appeal ruling against AXA (AXAHY) in their case against Santander (SAN) companies related to liabilities associated with…
Genworth Financial, Inc.: Genworth Issues Statement on Court of Appeal Ruling Against AXA in UK Payment Protection Insurance Case
Genworth Financial, Inc. (NYSE: GNW) today issued a statement in response to a UK Court of Appeal ruling against AXA in their case against Santander companies related to liabilities associated wit...
Genworth Issues Statement on Court of Appeal Ruling Against AXA in UK Payment Protection Insurance Case
Genworth Financial, Inc. (NYSE: GNW) today issued a statement in response to a UK Court of Appeal ruling against AXA in their case against Santander companies related to liabilities associated with th...
Axa bets on AI and automation to deliver boost of up to £600 million
Axa said it expects to generate between 500 and 700 euro (£428 million – £599 million) worth of annual benefits from AI by 2029.
AXA SA Transcript: CMD 2026
The new strategic plan targets 7%-9% EPS growth and 15%-17% ROE, driven by organic growth, disciplined capital allocation, and AI-powered efficiency. Growth will be broad-based across P&C, health, and life, with a focus on retention, direct, and inclusive insurance, while maintaining robust margins and a resilient balance sheet.
AXA SA Press release: FY 2026
AXA SA issued a press release on September 15, 2026, disclosing material business information to investors.
AXA SA Slides: FY 2026
AXA SA has posted slides in relation to its FY 2026 quarterly earnings report, which was published on September 15, 2026.
Axa raises earnings targets in new three-year plan
Axa raised its profitability and cash-generation targets for 2027 to 2029 on Tuesday, saying its diversified business would drive earnings growth despite softening market conditions at Axa XL.
AXA Targets More Growth With New Targets
The French insurer said earnings should keep growing over the next few years as it intends to gain market share after years of reorganization.
AXA downgraded to Hold from Buy at Erste Group
Erste Group analyst Hans Engel downgraded AXA (AXAHY) to Hold from Buy. AXA is undergoing a transformation following the sale of its asset management division to BNP Paribas, says the…
AXA price target raised to EUR 52 from EUR 50 at JPMorgan
JPMorgan raised the firm’s price target on AXA (AXAHY) to EUR 52 from EUR 50 and keeps an Overweight rating on the shares.
AXA price target raised to EUR 50.40 from EUR 46.82 at Citi
Citi raised the firm’s price target on AXA (AXAHY) to EUR 50.40 from EUR 46.82 and keeps a Buy rating on the shares.
AXA price target raised to EUR 48 from EUR 46 at Morgan Stanley
Morgan Stanley raised the firm’s price target on AXA (AXAHY) to EUR 48 from EUR 46 and keeps an Overweight rating on the shares.
AXA SA Earnings Call Transcript: Q2 2026
Strong H1 2026 results with 5% organic growth, 8% Underlying EPS growth, and 18% ROE, supported by a robust Solvency II ratio of 218%. All segments and geographies contributed, with P&C and Life & Health showing margin and earnings improvements.
AXA SA Quarterly report: Q2 2026
AXA SA has published its Q2 2026 quarterly earnings report on July 31, 2026.